Department of Microbiology and Virology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Arch Med Res. 2022 Sep;53(6):634-640. doi: 10.1016/j.arcmed.2022.08.010. Epub 2022 Sep 9.
The emergence and global spread of multidrug-resistant Helicobacter pylori (MDR H. pylori) is a major health problem in children, which can increase the risk of serious complications such as gastric cancer. The aim of this study was to determine the prevalence of primary MDR H. pylori in children via a comprehensive systematic literature review and meta-analysis.
All potential studies were collected from international databases like: ISI Web of Science, Embase, PubMed, Google Scholar, and Scopus from 2011-July 24, 2022. Ultimately, primary MDR H. pylori in children was measured as an event rate with corresponding 95% confidence intervals.
A total of 19 studies met the inclusion criteria. The overall prevalence of primary MDR H. pylori in children was measured at 6.0% (95% CI: 3.1-11.6); There was a significant difference in primary MDR H. pylori resistance rates between Asian populations and Western countries.
The global spread of MDR H. pylori strains could significantly limit the options of anti-H. pylori treatment regimens. The frequency of primary MDR H. pylori infection differs between various geographical regions. Thus, drug susceptibility testing and the eradication of H. pylori infection can effectively reduce and control the spread of H. pylori antibiotic resistance throughout the world.
多药耐药幽门螺杆菌(MDR H. pylori)的出现和全球传播是儿童健康的主要问题,它会增加胃癌等严重并发症的风险。本研究旨在通过全面的系统文献回顾和荟萃分析来确定儿童原发性 MDR H. pylori 的流行率。
从国际数据库(如 ISI Web of Science、Embase、PubMed、Google Scholar 和 Scopus)收集所有潜在的研究,检索时间从 2011 年至 2022 年 7 月 24 日。最终,将儿童原发性 MDR H. pylori 以事件发生率及其相应的 95%置信区间来衡量。
共有 19 项研究符合纳入标准。儿童原发性 MDR H. pylori 的总体流行率为 6.0%(95%CI:3.1-11.6);亚洲人群和西方国家的原发性 MDR H. pylori 耐药率存在显著差异。
MDR H. pylori 菌株的全球传播可能会显著限制抗 H. pylori 治疗方案的选择。不同地理区域的原发性 MDR H. pylori 感染频率存在差异。因此,药敏试验和 H. pylori 感染的根除可以有效减少和控制全球范围内 H. pylori 抗生素耐药性的传播。